Clinical trial
A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary…
NCT00301535 · Biopure Corporation, Industry · Unknown status
Key facts
| NCT number | NCT00301535 |
|---|---|
| Title | A Study of Hemopure® to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery |
| Official title | Enhancement of Tissue Preservation During Cardiopulmonary Bypass With HBOC-201 (Registry Study) |
| Lead sponsor | Biopure Corporation, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | HBOC-201 (hemoglobin glutamer-250 bovine) |
| Enrollment | 60 |
| Start date | Feb 1, 2006 |
| Primary completion | Jul 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Mar 13, 2006 |
| Last update posted | May 16, 2008 |
| Countries | Greece, South Africa, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: